CIK 0001730463 · Non-accelerated filer<br>Smaller reporting company
Autolus Therapeutics plc
Sign in to watch- Ticker
- AUTL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 20 3829 6230
- Business address
- THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
- Former names
- Autolus Therapeutics Ltd
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- DEL AM Other DEL AM
- S-3 Offering Registration Statement
- 4 Open-market sale U.S. CCO & Country Gen Manager sold 6,713 shares at $2.34 ($15,682)
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 17 · 340 filings